<?xml version="1.0" ?><!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st June 2018//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_180601.dtd"><PubmedArticleSet><PubmedArticle>    <MedlineCitation Status="Publisher" Owner="NLM">        <PMID Version="1">30334925</PMID>        <DateRevised>            <Year>2018</Year>            <Month>10</Month>            <Day>18</Day>        </DateRevised>        <Article PubModel="Print-Electronic">            <Journal>                <ISSN IssnType="Electronic">1539-2864</ISSN>                <JournalIssue CitedMedium="Internet">                    <PubDate>                        <Year>2018</Year>                        <Month>Oct</Month>                        <Day>16</Day>                    </PubDate>                </JournalIssue>                <Title>Retina (Philadelphia, Pa.)</Title>                <ISOAbbreviation>Retina (Philadelphia, Pa.)</ISOAbbreviation>            </Journal>            <ArticleTitle>UVEAL METASTASIS BASED ON PATIENT AGE IN 1,111 PATIENTS: Comparison of Clinical Features and Outcomes Per Age Category.</ArticleTitle>            <ELocationID EIdType="doi" ValidYN="Y">10.1097/IAE.0000000000002364</ELocationID>            <Abstract>                <AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">To evaluate clinical features and survival outcomes of uveal metastasis based on patient age.</AbstractText>                <AbstractText Label="METHODS" NlmCategory="METHODS">Retrospective analysis of all patients with uveal metastasis evaluated on the Ocular Oncology Service, Wills Eye Hospital, Philadelphia, PA, USA between February 1, 1974 and June 1, 2017. The features and outcomes were analyzed based on patient age classified as children (0-20 years), young adults (21-40 years), middle [aged] adults (41-60 years), older adults (61-80 years) and senior adults (81-100 years).</AbstractText>                <AbstractText Label="RESULTS" NlmCategory="RESULTS">There were 1111 consecutive patients, including children (n = 3, &lt;1%), young adults (n = 77, 7%), middle adults (n = 472, 42%), older adults (n = 509, 46%), and senior adults (n = 50, 4%). At uveal metastasis diagnosis, demographics included mean patient age of 60 years, Caucasian race (88%), and female gender (64%). Compared to the largest cohort (older adults), there were significant differences (age group versus [vs.] older adults) in Caucasian race (senior adult 98% vs. 89%, p = 0.042), male sex (young adults: 22% vs. 43%, p &lt; 0.001) (middle adults: 29% vs. 43%, p &lt; 0.001), unilateral tumor (young adult: 70% vs. 86%, p &lt; 0.001) (middle adult: 79% vs. 86%, p = 0.003) (senior adults: 96% vs. 86%, p = 0.045), and cancer origin in breast (young adults: 51% vs. 32%, p = 0.002) (middle adults: 44% vs 32%, p &lt; 0.001), lung (young adults: 14% vs. 30%, p = 0.004), kidney (young adults: 0% vs. 5%, p = 0.043), prostate (middle adults: 1% vs. 4%, p = 0.001), gastrointestinal tract (senior adults: 8% vs. 2%, p = 0.028), and others (children: 100% vs. 4%, p &lt; 0.001) (young adults: 10% vs. 4%, p = 0.044). Kaplan-Meier survival (children, young, middle, older, and senior adults) at 1 year was 33%, 48%, 60%, 62%, and 76% and at 5 years was 0%, 22%, 29%, 25%, and 40%, respectively, with no difference per age category. The mean overall survival was 17.2 months and children demonstrated hazard ratio (HR) for death at 1 year of 2.1 relative to older adults.</AbstractText>                <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Uveal metastasis is found in all age groups. Compared to older adults, primary cancer site was more often breast and less likely lung in young and middle adults. Other rare sites were more often seen in children. Survival outcomes at 1 and 5 years were most favorable for senior adults and least favorable for children.</AbstractText>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Shields</LastName>                    <ForeName>Carol L</ForeName>                    <Initials>CL</Initials>                    <AffiliationInfo>                        <Affiliation>Ocular Oncology Service, Wills Eye Hospital, Thomas Jefferson University, Philadelphia, Pennsylvania.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Acaba-Berrocal</LastName>                    <ForeName>Luis A</ForeName>                    <Initials>LA</Initials>                </Author>                <Author ValidYN="Y">                    <LastName>Selzer</LastName>                    <ForeName>Evan B</ForeName>                    <Initials>EB</Initials>                </Author>                <Author ValidYN="Y">                    <LastName>Mayro</LastName>                    <ForeName>Eileen L</ForeName>                    <Initials>EL</Initials>                </Author>                <Author ValidYN="Y">                    <LastName>Newman</LastName>                    <ForeName>Jennifer H</ForeName>                    <Initials>JH</Initials>                </Author>                <Author ValidYN="Y">                    <LastName>Malik</LastName>                    <ForeName>Kunal</ForeName>                    <Initials>K</Initials>                </Author>                <Author ValidYN="Y">                    <LastName>Welch</LastName>                    <ForeName>R Joel</ForeName>                    <Initials>RJ</Initials>                </Author>                <Author ValidYN="Y">                    <LastName>Shields</LastName>                    <ForeName>Jerry A</ForeName>                    <Initials>JA</Initials>                </Author>            </AuthorList>            <Language>eng</Language>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>            </PublicationTypeList>            <ArticleDate DateType="Electronic">                <Year>2018</Year>                <Month>10</Month>                <Day>16</Day>            </ArticleDate>        </Article>        <MedlineJournalInfo>            <Country>United States</Country>            <MedlineTA>Retina</MedlineTA>            <NlmUniqueID>8309919</NlmUniqueID>            <ISSNLinking>0275-004X</ISSNLinking>        </MedlineJournalInfo>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>10</Month>                <Day>19</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>10</Month>                <Day>20</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>10</Month>                <Day>20</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>aheadofprint</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30334925</ArticleId>            <ArticleId IdType="doi">10.1097/IAE.0000000000002364</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle></PubmedArticleSet>